Contingent Consideration - Schedule of Reconciliation of Contingent Consideration Liability Related to Acquisition (Details) - USD ($) $ in Thousands	3 Months Ended	8 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Business Acquisition Contingent Consideration [Line Items]
Change in fair value of contingent consideration	$ 71
Kuur Therapeutics, Inc.
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076
Ending balance	24,147	$ 24,076
Kuur Therapeutics, Inc. | Level 3 Inputs
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076
Ending balance	24,147	24,076
Kuur Therapeutics, Inc. | Level 3 Inputs | Fair Value, Recurring
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076	19,839
Change in fair value of contingent consideration	71	4,237
Ending balance	$ 24,147	$ 24,076